Literature DB >> 21316600

NEDD8 pathways in cancer, Sine Quibus Non.

Ian R Watson1, Meredith S Irwin, Michael Ohh.   

Abstract

There are 17 known ubiquitin-like proteins (UBLs) from nine phylogenetically distinct classes (NEDD8, SUMO, ISG15, FUB1, FAT10, Atg8, Atg12, Urm1, and UFM1) that have been identified to conjugate to substrates in a manner analogous to ubiquitin. NEDD8 is one of the most studied UBLs and shares the highest amino acid similarity to ubiquitin. Here, we review the current knowledge of the NEDD8 conjugation cascade derived from functional studies in genetic model organisms, structural insights from crystallographic studies, biochemical studies identifying a growing list of NEDD8 substrates with oncogenic implications, and attempts to pharmacologically target the NEDD8 pathway in cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21316600     DOI: 10.1016/j.ccr.2011.01.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  82 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

Review 2.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

3.  MLN4924 induces Noxa upregulation in acute myelogenous leukemia and synergizes with Bcl-2 inhibitors.

Authors:  K L B Knorr; P A Schneider; X W Meng; H Dai; B D Smith; A D Hess; J E Karp; S H Kaufmann
Journal:  Cell Death Differ       Date:  2015-06-05       Impact factor: 15.828

4.  The NEDD8 inhibitor MLN4924 increases the size of the nucleolus and activates p53 through the ribosomal-Mdm2 pathway.

Authors:  A Bailly; A Perrin; L J Bou Malhab; E Pion; M Larance; M Nagala; P Smith; M-F O'Donohue; P-E Gleizes; J Zomerdijk; A I Lamond; D P Xirodimas
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

5.  MLN4924 sensitizes monocytes and maturing dendritic cells for TNF-dependent and -independent necroptosis.

Authors:  Mohamed El-Mesery; Axel Seher; Thorsten Stühmer; Daniela Siegmund; Harald Wajant
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

6.  Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer.

Authors:  Daniel B Longley; Victoria Coyle; Jennifer Ferris; Margarita Espona-Fiedler; Claudia Hamilton; Caitriona Holohan; Nyree Crawford; Alex J McIntyre; Jamie Z Roberts; Mark Wappett; Simon S McDade
Journal:  Cell Death Discov       Date:  2020-07-21

Review 7.  Posttranslational modification and quality control.

Authors:  Xuejun Wang; J Scott Pattison; Huabo Su
Journal:  Circ Res       Date:  2013-01-18       Impact factor: 17.367

8.  Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.

Authors:  Hua Li; Mingjia Tan; Lijun Jia; Dongping Wei; Yongchao Zhao; Guoan Chen; Jie Xu; Lili Zhao; Dafydd Thomas; David G Beer; Yi Sun
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

Review 9.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

Review 10.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.